Representative(s): Christine Campione Marc Wait
| Sanofi Genzyme is the specialty care global business unit of Sanofi. We strive to help people with complex conditions that may be difficult to treat. Our approach is shaped by our experience developing highly specialized treatments and forging close relationships with physician and patient communities. We are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Learn more at www.sanofigenzyme.com. Brand Information: SarclisaHCP.com: https://www.https://www.sarclisahcp.com/ Sarclisa (isatuximab-irfc) Prescribing Information: http://products.sanofi.us/Sarclisa/sarclisa.pdf Elitekpro.com: https://www.elitekpro.com/ Elitek (rasburicase) Prescribing Information, Including Boxed WARNING: http://products.sanofi.us/elitek/Elitek.html Flashcard_Anticancer Therapies (SAUS.RAS_.20.02.0751).pdf Flashcard_Efficacy and High Risk (SAUS.RAS_.20.02.0757).pdf SARCLISA Clinicians Guide_MAT-US-2004952-v2.0.pdf SARCLISA_MAT-US-2016921_DIGITAL_Brand Story & NCCN Leave Behind_Hyperlinked_FINAL.pdf SARCLISA_MAT-US-2018087_DIGITAL_Patient Profile_Lynn_FINAL.pdf | Virtual Drop InMarch 6th, 7:30 a.m. – 12:30 p.m. CST Click here to join the zoom meeting
If you must dial-in: US: +1 312 626 6799 Meeting ID: 932 5333 5153
|